CDKN2A and mesothelioma: Many recent studies have used MTAP IHC to increase the sensitivity in diagnosing mesothelioma (8, 13, 14, 22, 25), since previous studies indicated that p16 IHC has poor concordance with homozygous CDKN2A loss in MPM (9, 14).